Home > Insider Trading > Filing (0001209191-21-067878)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1408500	E Martin Cearnal	2525 West End Ave. Suite 950 Nashville TN 37203	Sr Vp/Chief Commercial Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-11-01	105	$2.67	173,979	No	4	P	Direct
Common Stock	Acquisiton	2021-11-02	105	$2.63	174,084	No	4	P	Direct
Common Stock	Acquisiton	2021-11-03	105	$2.71	174,189	No	4	P	Direct
Common Stock	Acquisiton	2021-11-04	105	$2.73	174,294	No	4	P	Direct
Common Stock	Acquisiton	2021-11-05	105	$2.71	174,399	No	4	P	Direct
Common Stock	Acquisiton	2021-11-08	105	$2.95	174,504	No	4	P	Direct
Common Stock	Acquisiton	2021-11-09	105	$3.21	174,609	No	4	P	Direct
Common Stock	Acquisiton	2021-11-10	105	$2.94	174,714	No	4	P	Direct
Common Stock	Acquisiton	2021-11-11	105	$2.83	174,819	No	4	P	Direct
Common Stock	Acquisiton	2021-11-12	105	$2.67	174,924	No	4	P	Direct
Common Stock	Acquisiton	2021-11-15	105	$2.71	175,029	No	4	P	Direct
Common Stock	Acquisiton	2021-11-16	105	$2.66	175,134	No	4	P	Direct
Common Stock	Acquisiton	2021-11-17	105	$2.58	175,239	No	4	P	Direct
Common Stock	Acquisiton	2021-11-18	105	$2.58	175,344	No	4	P	Direct
Common Stock	Acquisiton	2021-11-19	105	$2.55	175,449	No	4	P	Direct
Common Stock	Acquisiton	2021-11-22	105	$2.35	175,554	No	4	P	Direct
Common Stock	Acquisiton	2021-11-23	105	$2.29	175,659	No	4	P	Direct
Common Stock	Acquisiton	2021-11-24	175	$2.31	175,834	No	4	P	Direct
Common Stock	Acquisiton	2021-11-26	175	$2.26	176,009	No	4	P	Direct
Common Stock	Acquisiton	2021-11-29	175	$2.23	176,184	No	4	P	Direct
Common Stock	Acquisiton	2021-11-30	175	$4.61	176,359	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.